Intellectual property 2,876,325 15,194,606
-------------------------------------------------------------------------
50,312,095 54,474,961
-------------------------------------------------------------------------
-------------------------------------------------------------------------
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Bank indebtedness 6,476,288 -
Accounts payable and accrued liabilities 14,410,438 10,201,378
Fair value of derivative financial instruments 41,175 -
Current portion of long-term debt 1,236,032 -
Current portion of deferred revenue 615,546 491,683
-------------------------------------------------------------------------
Total current liabilities 22,779,479 10,693,061
Long-term debt 22,927,229 22,399,317
Deferred revenue 294,169 228,774
-------------------------------------------------------------------------
Total liabilities 46,000,877 33,321,152
-------------------------------------------------------------------------
Commitments and contingencies
Shareholders' equity
Capital stock 181,041,609 180,655,193
Contributed surplus 9,215,635 7,469,343
Deficit (185,946,026) (166,970,727)
-------------------------------------------------------------------------
Total shareholders' equity 4,311,218 21,153,809
-------------------------------------------------------------------------
'/>"/>
| SOURCE CryoCath Technologies Inc. Copyright©2007 PR Newswire. All rights reserved |